期刊文献+

中国支气管扩张症:十余年成就与未来展望

Bronchiectasis in China:achievements in the past decade and future prospects
原文传递
导出
摘要 支气管扩张症(支扩)是一种由支气管阻塞及其周围肺组织的慢性炎症引起的呼吸系统疾病,其典型的病理特征是支气管壁结构损伤,以及管腔持久性、不可逆性扩张。支扩是一种未被充分重视的常见病,近十余年来,临床医生对支扩的流行病学、病理学、临床表现、诊断和治疗等方面有了更为系统的认识。本文扼要总结中国近十余年来在支扩临床实践和研究方面的主要成就,并对未来进行展望,以飨读者。 Bronchiectasis(BE)is a respiratory disease caused by chronic inflammation of the bronchial and the surrounding lung tissue due to bronchial obstruction.Its typical pathological features include the injured bronchial wall structure,and persistent and irreversible dilation of the lumen.BE is a common disease that has not been given sufficient attention.During the past decade,clinicians have gained a more systematic understanding of the epidemiology,pathology,clinical manifestations,diagnosis and treatment of BE.This article briefly summarized the main progress in the clinical practice and research of BE in China over the past decade,and offers insights into the future.
作者 徐金富 Xu Jinfu(Department of Respiratory and Critical Care Medicine,Huadong Hospital,Fudan University,Shanghai 200040,China)
出处 《国际呼吸杂志》 2025年第1期2-7,共6页 International Journal of Respiration
基金 国家自然科学基金(81925001、82330070) 四大慢病重大专项(2024ZD0522400)。
关键词 支气管扩张症 诊断 治疗 进展 Bronchiectasis Diagnosis Therapy Progress
作者简介 徐金富,Email:jfxucn@163.com。
  • 相关文献

参考文献13

二级参考文献136

  • 1Xia Xu,Haiwen Lu,Jianxiong Li,Jielin Duan,Zhongwei Wang,Jiawei Yang,Shuyi Gu,Rongguang Luo,Shuo Liang,Wei Tang,Fengying Zhang,Jingqing Hang,Juan Ge,Xin Lin,Jieming Qu,Xinming Jia,Jinfu Xu.Heterozygous CARD9 mutation favors the development of allergic bronchopulmonary aspergillosis[J].Chinese Medical Journal,2023,136(16):1949-1958. 被引量:2
  • 2卢树标,吕文慧,荣福.支气管扩张病例应用23价肺炎球菌多糖疫苗的临床观察[J].海军医学杂志,2006,27(3):205-207. 被引量:6
  • 3Woodhead M, Blasi F, Ewig S, et al. European Respiratory Society; European Society of Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J,2005,26 : 1138-1180.
  • 4Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections - - full version. Clin Microbiol Infect, 2011, 17 Suppl 6: El-E59.
  • 5Pasteur MC, Bilton D, Hill AT, et al. British Thoracic Society guideline for non-CF bronchiectasis. Thorax,2010,65 Suppl 1 :i1- 58.
  • 6Weycker D, Edelsberg J, Oster G, et al. Prevalence and economic burden of bronchiectasis. Am J Respir Cfit Care Med, 2004,169 : A330.
  • 7Twiss J, Metcalfe R, Edwards E, et al. New Zealand national incidence of bronchiectasis "too high" for a developed country. Arch Dis Child,2005, 90:737-740.
  • 8Weycker D, Edelsberg J, Oster G, et al. Prevalence and economic burden of bronchiectasis. Clin Pulm M ed,2005,12:205- 209.
  • 9Crofton J. Bronchiectasis. In: Cmflon J, Douglas A, eds. Respiratory diseases. 3 rd eds. Oxford: Blackwell Scientific, 1981:417-430.
  • 10Patel IS, Vlahos I, Wilkinson TM, et al. Bronchiectasis, exacerbation indices and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2004,70 : 400- 407.

共引文献882

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部